SCHEMBL145178

SCHEMBL145178

CNC(=O)c1cccc(Br)c1F

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.56
PLK1 P53350 1/20 0.49
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 2/20 0.44
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
LCLAT1 Q6UWP7 1/20 0.40
PDK2 Q15119 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MTNR1A P48039 1/20 0.40
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HDAC2 Q92769 1/20 0.38
CES2 O00748 1/20 0.38
BCHE P06276 1/20 0.38
CES1 P23141 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29599784 0.85 HDAC8 (0.48) GAAALDH1A1KMT2AHDAC8HDAC6
SCHEMBL28709174 0.85 HDAC8 (0.48) GAAALDH1A1KMT2AHDAC8HDAC6
SCHEMBL21461009 0.81 CA1 (0.47) GAAALDH1A1KMT2ALCLAT1MEN1
SCHEMBL30367806 0.81 CA1 (0.47) GAAALDH1A1KMT2ALCLAT1MEN1
SCHEMBL1805144 0.81 GAA (0.71) GAAPLK1ALDH1A1KMT2APDK2
SCHEMBL1853517 0.80 ALDH1A1 (0.66) GAAPLK1ALDH1A1KMT2AHPGD
SCHEMBL24445885 0.79 GAA (0.58) GAAPLK1ALDH1A1PDK2HSD17B10
SCHEMBL2012174 0.79 PLK1 (0.50) GAAPLK1ALDH1A1KMT2AHDAC8
SCHEMBL8571882 0.79 GAA (0.58) GAAPLK1ALDH1A1KMT2ALCLAT1
SCHEMBL1849109 0.79 CES2 (0.42) ALDH1A1KMT2ALCLAT1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220370420-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2022-11-24 US disclosed
EP-2391602-B1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-12-04 EP disclosed
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220370420-A1 SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF HIPK1, NEK1, HIPK2 GAA 2833/4885PLK1 736/4885ALDH1A1 2398/4885
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 GAA 3409/4885PLK1 675/4885ALDH1A1 3832/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 GAA 3409/4885PLK1 675/4885ALDH1A1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.